T-Maze Spontaneous Alternation
Overview
The T-maze spontaneous alternation task exploits the innate tendency of rodents to explore novel environments by measuring their propensity to alternate arm choices across successive trials. Spatial working memory is assessed by the animal's ability to remember which arm was previously visited and choose the opposite arm on the subsequent trial. This paradigm is sensitive to hippocampal lesions, pharmacological manipulations targeting cholinergic and glutamatergic systems, and transgenic models of Alzheimer's disease.
Primary dependent variables include the percentage of spontaneous alternation (ratio of alternating choices to total possible alternations), arm entry latency, total number of arm entries, and time spent in each arm. Additional measures such as return latency (time between consecutive arm entries) and perseverative errors (repeated entries into the same arm) provide further insight into spatial working memory integrity and behavioral flexibility.
ConductMaze automates T-maze alternation testing with infrared beam-break arrays at arm entrances and choice points, enabling real-time detection of arm entries without manual observation. The system controls guillotine door actuators to manage forced-choice and free-choice phases, logs all spatial coordinates and timestamps, and computes alternation scores, latencies, and error types automatically. Session parameters including inter-trial interval, number of trials, and door timing are fully programmable.
Trial Flow
Place Animal
Subject is placed in the start arm of the T-maze facing the choice point.
Forced Run
One arm is blocked via guillotine door; animal enters the open arm (sample phase).
Confinement
Animal is confined in the chosen arm for the specified sample duration.
Return to Start
Animal is returned to start arm; both guillotine doors are opened simultaneously.
Free Choice
Animal chooses between left and right arms; entry is logged when all four paws cross the arm threshold.
Score Alternation
Choice is compared to previous trial; alternation or perseveration is recorded with latency.
Inter-Trial Interval
Animal is held in a waiting area for the configured ITI before the next trial begins.
Session Complete
After all trials are completed, summary statistics are computed and exported.
Parameters
| Parameter | Type | Default | Description |
|---|---|---|---|
| Number of Trials | integer | 14 | Total number of free-choice trials per session. |
| Inter-Trial Interval | duration | 30s | Time between the end of one trial and the start of the next. |
| Sample Duration | duration | 30s | Confinement time in the forced-choice arm during the sample phase. |
| Choice Timeout | duration | 120s | Maximum time allowed for the animal to make an arm choice. |
| Arm Entry Threshold | distance | 5cm | Distance past the choice point that constitutes a committed arm entry. |
| Forced Arm Sequence | enum | pseudorandom | Pattern of forced-choice arm assignments: alternating, random, or pseudorandom. |
| Door Close Delay | duration | 2s | Time after arm entry before the guillotine door closes behind the animal. |
Metrics
| Metric | Unit | Description |
|---|---|---|
| Alternation Rate | % | Percentage of trials where the animal chose the arm not visited on the previous trial. |
| Arm Entry Latency | s | Time from door opening to the animal crossing the arm entry threshold. |
| Perseverative Errors | count | Number of consecutive entries into the same arm across trials. |
| Total Arm Entries | count | Total number of arm entries across all trials in the session. |
| Time in Chosen Arm | s | Duration spent in the selected arm per trial before return. |
| Choice Point Hesitation | s | Time spent in the choice point zone before committing to an arm. |
Sample Data
| Trial | Forced Arm | Chosen Arm | Alternation | Latency (s) | Hesitation (s) |
|---|
Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.
Applications
- 1Hippocampal Function — Assessing spatial working memory deficits following dorsal hippocampal lesions or optogenetic silencing of CA1 pyramidal neurons.
- 2Alzheimer's Disease Models — Longitudinal tracking of cognitive decline in APP/PS1, 3xTg-AD, and 5xFAD transgenic mouse lines across age.
- 3Cholinergic Pharmacology — Evaluating procognitive effects of acetylcholinesterase inhibitors (donepezil, galantamine) and muscarinic receptor agonists.
- 4Neurodevelopmental Disorders — Characterizing spatial memory phenotypes in models of Down syndrome, Fragile X, and autism spectrum disorders.
- 5Acute Drug Screening — Rapid assessment of cognitive side effects for anxiolytics, antipsychotics, and novel compounds in preclinical pipelines.
Related Protocols
Compatible Products
Ready to Automate Your Behavioral Protocols?
Contact us for a demo and pricing information.